[GnRH analogues and myomas: which strategy?].
Poncelet
C
C
Service de gynécologie-obstétrique, CHU Jean-Verdier, Bondy, France. christophe.poncelet@jvr.ap-hop-paris.fr
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D010535:Laparoscopy / Q000379:methods; D007889:Leiomyoma / Q000188:drug therapy* / Q000601:surgery; D017697:Premenopause; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000628:therapy
D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone